| REG |
Report |
Nareit FFO per diluted share (Q2 2026) |
IN-LINE |
pred ~$1.20 vs. cons $1.20 |
HIGH |
| REG |
Report |
Same Property NOI growth (Q2 2026, y/y) |
IN-LINE |
pred ~2.5% vs. cons 2.6% |
MEDIUM |
| REG |
Report |
Total Revenue (Q2 2026) |
BEAT |
pred ~$411M vs. cons $407M |
MEDIUM |
| REG |
Guide |
FY2026 Nareit FFO per share guidance |
UNCHANGED |
guide ~$4.85 (reaffirm $4.83-$4.87) vs. cons $4.85 (FY2026) |
HIGH |
| REG |
Guide |
FY2026 Same Property NOI growth guidance |
UNCHANGED |
guide ~3.5% midpoint (reaffirm 3.25%-3.75%) vs. cons 3.5% (FY2026) |
MEDIUM |
| REG |
Guide |
FY2026 Development/redevelopment spend guidance |
BETTER |
guide ~$350-375M vs. cons ~$340M (FY2026) |
MEDIUM |
| REG |
Guide |
Bad debt / uncollectible lease income commentary |
UNCHANGED |
guide ~75bps of revenue (at/slightly below historical avg) vs. cons ~75bps (FY2026) |
LOW |
| REG |
Return |
Day-1 residual (stock − beta × S&P 500) |
+0.3% |
— |
MEDIUM |
| REG |
Return |
5-day cumulative residual |
+0.2% (STABILIZE) |
Q2 softness in headline Same-Property NOI was explicitly pre-announced last quarter (tough expense-recovery comp), so it's already embedded in consensus/guidance and shouldn't trigger fresh downward revisions to FY26/FY27 estimates. With FY guidance merely reaffirmed (not raised) and no change to the out-period FFO growth algorithm, there's little forward-estimate math to drive a big multi-day move either way — the stock, already up ~22% off its Dec low and near 52-week highs heading into the print, likely sees a muted initial reaction that holds rather than extends (no re-rating catalyst) or reverses sharply (no real negative surprise given management pre-telegraphed the comp issue and peer BRX's beat-and-raise supports sector fundamentals). |
MEDIUM |